Background and Objectives
There is an increasing use of social media amongst the urological community. However, it is difficult to identify urological data on various social media platforms in an efficient manner. We proposed a hashtag, #UroSoMe, to be used when posting urology-related content in the social media platforms. The objectives of this article are to describe how #UroSoMe was developed, and to report the data of the first month of #UroSoMe.
Material and Methods
The hashtag, #UroSoMe, was introduced to the urological community. The #UroSoMe working group was formed, and the members actively invited and encouraged people to use the hashtag #UroSoMe when posting urology-related contents. After the #UroSoMe (@so_uro) platform on twitter had grown to more than 300 users, the first live event of online case discussion, i.e. #LiveCaseDiscussions, was conducted. A prospective observational study of the hashtag #UroSoMe Twitter activity during the first month of its usage from 14 December 2018 to 13 January 2019 was evaluated. Outcome measures included number of users, number of tweets, user location, top tweeters, top hashtags used and interactions. Analysis was performed using NodeXL (Social Media Research Foundation; California, USA; https://www.smrfoundation.org/nodexl/), Symplur (https:// www.symplur.com) and Twitonomy (https://www.twitonomy.com).
Results
The first month of #UroSoMe activity documented 1373 tweets/retweets by 1008 tweeters with 17698 mentions and 1003 replies. The #LiveCaseDiscussions was able to achieve a potential reach of 2,033,352 Twitter users. The top tweets mainly included cases presented by #UroSoMe working group members during #LiveCaseDiscussions. The twitonomy map showed participation from 214 geographical locations. The major groups of participants using the hashtag #UroSoMe were ‘Researcher/Academic’ and ‘Doctor’. The twitter account of #UroSoMe (@so_uro) has now grown to more than 1000 followers.
Conclusions
Social media is an excellent platform for interaction amongst the urological community. The results demonstrated that #UroSoMe was able to achieve wide spread engagement from all over the world.
Introduction
Traditional intravesical chemotherapy instillations under room temperature post trans-urethral resection (TUR) of non-muscle invasive bladder cancer (NMIBC) have lower efficacies than maintenance BCG installations. Intravesical chemo-hyperthermia (CHT) at higher temperatures is developed to improve the efficacy of chemotherapy instillation. This systematic review aims to compare the use of CHT and BCG instillation post-TUR.
Method
The protocol of this review is registered on PROSPERO(CRD42020223277). A comprehensive literature search was performed on Medline, EMBASE, and Cochrane CENTRAL to identify studies comparing CHT and BCG post-TUR for intermediate- or high-risk NMIBC. Primary outcomes include recurrence-free survival (RFS) and progression-free survival (PFS). Secondary outcomes include adverse events (AE).
Results
From 2,375 identified records, four randomised control trials incorporating 327 patients were included for meta-analysis. The use of CHT was found to be non-inferior to BCG in RFS, PFS and AEs (Grades 1-3) (p > 0.05). Sensitivity analysis, excluding patients with BCG failures, show 24-36 months recurrence rate to be significantly lower in CHT group (RR 0.64, 95% CI 0.42-0.98, p = 0.04) compared to the BCG group. In patients without carcinoma in situ (CIS), RFS is also significantly better in CHT patients (HR 0.52, 95% CI 0.32- 0.85, p < 0.01). Safety profile remains non-inferior to the BCG group in sensitivity analyses. Quality of evidence across all outcomes ranged from moderate to low.
Conclusions
In well-selected patients, intravesical CHT has superior oncological outcomes and non-inferior safety profile when compared to BCG maintenance therapy for patients with intermediate- and high-risk NMIBC. CHT is a possible alternative treatment during BCG shortage.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.